CPSF7 anticorps (C-Term)
Aperçu rapide pour CPSF7 anticorps (C-Term) (ABIN629876)
Antigène
Voir toutes CPSF7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- FLJ12529 antibody was raised against the C terminal of FLJ12529
-
Purification
- Purified
-
Immunogène
- FLJ12529 antibody was raised using the C terminal of FLJ12529 corresponding to a region with amino acids GASGSSSRKRHRSRERSPSRSRESSRRHRDLLHNEDRHDDYFQERNREHE
-
-
-
-
Indications d'application
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
FLJ12529 Blocking Peptide, (ABIN938558), is also available for use as a blocking control in assays to test for specificity of this FLJ12529 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of FLJ12529 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CPSF7 (Cleavage and Polyadenylation Specific Factor 7, 59kDa (CPSF7))
-
Autre désignation
- FLJ12529
-
Sujet
- FLJ12529 is a probable component of the cleavage factor Im complex (CFIm) that plays a key role in pre-mRNA 3' processing.
-
Poids moléculaire
- 52 kDa (MW of target protein)
Antigène
-